Introduction: A Smarter Approach to Prostate Cancer Screening
For many years, prostate cancer screening has relied heavily on the prostate-specific antigen (PSA) test — a simple blood test used by doctors worldwide, including at our private GP surgery in Fulham. While the PSA test is widely available, it is not perfect. Elevated PSA levels don’t always mean cancer, often leading to unnecessary biopsies, MRI scans, and patient anxiety.
Today, more advanced tools such as the Stockholm3 test (STHLM3) are transforming prostate cancer detection. Despite its name sounding like a 90s indie band, Stockholm3 offers a serious advantage: greater accuracy with fewer unnecessary procedures.
If you’re considering prostate cancer screening in London, here’s what you should know about the latest innovations.
The PSA Test: Useful but Limited
The PSA test measures prostate-specific antigen levels in the blood, helping to identify potential prostate issues. However, high PSA levels can also be caused by benign prostate enlargement, infections, or inflammation — not just cancer.
Because of this low specificity, many men undergo unnecessary biopsies and scans. At our Fulham GP clinic, we prioritise screening methods that reduce these risks while maintaining diagnostic accuracy.
Stockholm3 Test: A Game-Changer in Prostate Cancer Screening
The Stockholm3 test takes prostate screening beyond PSA alone. It combines:
- Biomarkers – advanced blood-based indicators of prostate health
- Genetic testing – evaluating hereditary risks
- Clinical data – such as age, family history, and medical history
How Stockholm3 Improves Diagnosis
A major clinical study showed that Stockholm3 reduced the need for biopsies by 32% while still detecting aggressive cancers with high accuracy.
The National Institute for Health and Care Excellence (NICE) has also recognised Stockholm3’s potential to make prostate cancer screening more efficient, cutting down on unnecessary MRI scans and biopsies.
Reflex Testing: Smarter Use of PSA Results
At our private GP clinic in Fulham, Stockholm3 is used as a reflex test:
- If PSA levels are elevated, Stockholm3 evaluates additional genetic and clinical risk factors.
- This determines whether a biopsy is genuinely needed.
The result? Fewer unnecessary procedures, less anxiety, and more precise detection of high-risk patients.
Proven Accuracy Across All Ethnicities
One major concern with traditional screening methods is their varying accuracy across ethnic groups. The SEPTA trial in North America confirmed that Stockholm3 works reliably across diverse populations, with:
- Higher specificity – fewer false positives
- Non-inferior sensitivity – effective detection of all significant cancers
This makes Stockholm3 an important breakthrough, especially since ethnicity is a known risk factor in prostate cancer.
The Future of Prostate Cancer Screening in London
Advancements like Stockholm3 represent a shift toward personalised, risk-based screening. At our Fulham clinic, we are committed to offering the most advanced technologies for early and accurate prostate cancer detection.
If you’re considering prostate cancer screening in London, our private GPs provide:
- Comprehensive prostate health assessments
- Advanced genetic testing
- Next-generation screening methods